Paper · 683306

Opposing effects of tumor promoters on erythroid differentiation.

Miao RM and 2 others. Nature, 1978. Cited by 118 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Opposing effects of tumor promoters on erythroid differentiation. Papers, record 683306. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/683306

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Opposing effects of tumor promoters on erythroid differentiation.; PubMed
Journal: Nature; PubMed
Year: 1978; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/683306/; PubMed
DOI: https://doi.org/10.1038/274271a0; PubMed
The journal: https://conductscience.org/library/journal-index/0410462; PubMed
Citations, by iCite: 118; iCite
Relative citation ratio, by iCite: 3.26; iCite
Revised in PubMed: 2019-06-17; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Miao RM	R M
2	Filedsteel AH	A H
3	Fodge DW	D W

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Erythropoiesis	Major topic
Phorbols	Major topic
Tetradecanoylphorbol Acetate	Major topic
Acetamides
Cell Differentiation
Cell Line
Dimethyl Sulfoxide
Friend murine leukemia virus
Hypoxanthines
Rauscher Virus

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.

PMID	Title	Journal	Year	In Papers	Source
28,305,288	Modulatory action of 12-O-tetradecanoylphorbol-13-acetate on bud production inHydra.	Wilehm Roux Arch Dev Biol	1981	https://conductscience.org/library/papers/28305288	PubMed
6,968,905	Tumor promoters enhance myeloid and erythroid colony formation by normal mouse hemopoietic cells.	Proc Natl Acad Sci U S A	1980	https://conductscience.org/library/papers/6968905	PubMed
6,967,217	Phorbol esters induce differentiation in human malignant T lymphoblasts.	Proc Natl Acad Sci U S A	1980	https://conductscience.org/library/papers/6967217	PubMed
6,943,571	On the possibility of metabolic control of replicon "misfiring": relationship to emergence of malignant phenotypes in mammalian cell lineages.	Proc Natl Acad Sci U S A	1981	https://conductscience.org/library/papers/6943571	PubMed
6,940,185	Down regulation of specific binding of [20-3H]phorbol 12,13-dibutyrate and phorbol ester-induced differentiation of human promyelocytic leukemia cells.	Proc Natl Acad Sci U S A	1981	https://conductscience.org/library/papers/6940185	PubMed
6,940,123	Alterations in polyamine levels induced by phorbol diesters and other agents that promote differentiation in human promyelocytic leukemia cells.	Proc Natl Acad Sci U S A	1981	https://conductscience.org/library/papers/6940123	PubMed
6,934,543	Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy.	Proc Natl Acad Sci U S A	1980	https://conductscience.org/library/papers/6934543	PubMed
6,934,372	The effect of tumor-promoting phorbol diesters on terminal differentiation of cells in culture.	Mol Cell Biochem	1980	https://conductscience.org/library/papers/6934372	PubMed
6,929,508	Control of differentiation of a mammary cell line by lipids.	Proc Natl Acad Sci U S A	1980	https://conductscience.org/library/papers/6929508	PubMed
6,574,466	Opposing effects of interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast cultures.	Proc Natl Acad Sci U S A	1983	https://conductscience.org/library/papers/6574466	PubMed

1 to 10 of 19

See all 19 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/683306

GET https://conductscience.org/api/papers/v1/683306/authors

API reference For AI assistants